Platelet cytosolic calcium hyperresponsivity to serotonin in patients with hypertension and depressive symptoms

Biological Psychiatry

Volumn 45, Issue 8, 1999, Pages 1035-1041

  Delisi, John Stephen M ^a,b   Konopka, Lukasz M ^a,b   Russell, Karen ^a   O'Connor, Francine L ^a   Cooper, Richard ^b   Crayton, J W ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Affective disorders; Calcium; Depression; Hypertension; Platelet; Serotonin

Indexed keywords

CALCIUM ION; SEROTONIN;

ADULT; AGED; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PLATELETS; CALCIUM; DEPRESSIVE DISORDER, MAJOR; HUMANS; HYPERTENSION; INTRACELLULAR MEMBRANES; MALE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0033560702     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00157-7     Document Type: Article

References (38)

1. Beck A.T., Steer R.A. Manual for the Revised Beck Depression Inventory. 1987;The Psychological Corp, San Antonio, TX.
2. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety Psychometric properties . J Consult Clin Psychol. 56:1988;893-897.
3. Blakely R.D. Advances in the molecular biology of neurotransmitter transporters. Curr Opin Psychiatry. 5:1992;69-73.
4. Blockmans D., Deckmyn H., Vermylen J. Platelet activation. Blood Rev. 9:1995;143-156.
5. Cook E.J., Fletcher K.E., Wainwright M., et al. Primary structure of the human platelet serotonin 5-HT2A receptor Identity with frontal cortex serotonin 5-HT2A receptor . J Neurochem. 63:1994;465-469.
6. Dale J., Landmark K.H., Myhre E. The effects of nifedipine, a calcium antagonist, on platelet function. Am Heart J. 105:(1):1983;103-105.
7. Davis J.W., Arnold J. Time course of some effects of cigarette smoking on platelets. J Int Med. 231:1992;31-36.
8. Davis J.W., Shelton L., Watanabe I.S., Arnold J. Passive smoking affects endothelium and platelets. Arch Intern Med. 149:1989;386-389.
9. Dean W.L., Pope J.E., Brier M.E., Aronoff G.R. Platelet calcium transport in hypertension. Hypertension. 23:1994;31-37.
10. Delisi S.M., Konopka L.M., O'Connor F.L., Crayton J.W. Platelet cytosolic calcium responses to serotonin in depressed patients and controls Relationship to symptomatology and medication . Biol Psychiatry. 43:1998;327-334.
11. Ding Y., Chou T., Huan R. Are platelet cytosolic free calcium, serotonin concentration and blood viscosity different between hypertensive and normotensive subjects? Cardiology. 85:1994;76-81.
12. Dubovsky S.D., Thomas M., Hijazi A., Murphy J. Intracellular calcium signaling in peripheral cells of patients with bipolar affective disorder. Eur Arch Psychiatry Clin Neurosci. 243:1994;229-234.
13. Eckert A., Gann H., Riemann D., Aldenhoff J., Muller W.E. Elevated intracellular calcium levels after 5-HT2 receptor stimulation in platelets of depressed patients. Biol Psychiatry. 34:1993;565-568.
14. Frasure-Smith N., Lesperance F., Talajic M. Depression following myocardial infarction. JAMA. 270:1993;1819-1825.
15. Gleerup G., Mehlsen J., Winther K. Does calcium channel blockade and b-adrenergic blockade affect platelet function and fibrinolysis to a varying degree? J Cardiovasc Pharmacol. 25:1995;87-89.
16. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 260:1985;3440-3450.
17. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 32:1959;50-55.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-61.
19. Haynes D.H. Effects of cyclic nucleotides and protein kinases on platelet calcium homeostasis and mobilization. Platelets. 4:1993;231-242.
20. Ikeda T., Nonaka Y., Goto A., Ishii M. Effects of prazosin on platelet aggregation and plasma beta-thromboglobulin in essential hypertension. Clin Pharmacol Ther. 37:1985;601-605.
21. Konopka L., Cooper R., Crayton J. Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients. Biol Psychiatry. 39:1996;708-713.
22. Kusumi I., Kyoama T., Yamashita I. Serotonin-stimulated Ca2+ response is increased in the blood platelets of depressed patients. Biol Psychiatry. 30:1991;310-312.
23. Laghrissi-Thode F., Wagner W.R., Pollock B.G., Johnson P.C., Finkel M.S. Elevated platelet factor 4 and b-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry. 42:(4):1997;290-295.
24. Marchusson J.O., Ross S.B. Binding of some antidepressants to the 5-hydroxytryptamine transporter in brain and platelets. Psychopharmacology (Berl). 102:1990;145-155.
25. McFadden E.P., Clarke J.G., Davies G.J., Kaski J.C., Haider A.W., Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med. 324:1991;648-654.
26. Meltzer HY, Arora RC (1991): Platelet serotonin studies in affective disorders: Evidence for a serotoninergic abnormality? In: 5-Hydroxytriptamine in Psychiatry: A Spectrum of Ideas, Sandler M, Coppen A, Harnett S, editors. Oxford: Oxford University Press, pp 50-89.
27. Mikuni M., Kagaya A., Takahashi K., Meltzer H.Y. Serotonin but not norepinephrine-induced calcium mobilization of platelets is enhanced in affective disorder. Psychopharmacology (Berl). 106:1992;311-314.
28. Mundal H.H., Gjesdal K., Landmark K. The effect of n-3 fatty acids and nifedipine on platelet function in hypertensive males. Thromb Res. 72:1993;257-262.
29. Murray C.J., Lopez A.D. Evidence-based health policy - Lessons from the Global Burden of Disease Study. Science. 274:1996;740-743.
30. Musselman D.L., Tomer A., Manatunga A.K., et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 153:1996;1313-1317.
31. Pfueller S.L., Burns P., Mak K., Firkin B.G. Effects of nicotine on platelets function. Haemostasis. 18:1988;163-169.
32. Pittilo R.M., Clarke J.M.F., Harris D., et al. Cigarette smoking and platelet adhesion. Br J Haematol. 58:1984;627-632.
33. Ross R. The pathogenesis of atherosclerosis - An update. N Engl J Med. 314:1986;448-500.
34. Sheline Y.I., Bardgett M.E., Jackson J.L., Newcomer J.W., Csernansky J.G. Platelet serotonin markers and depressive symptomatology. Biol Psychiatry. 37:1995;442-447.
35. Simonsick E.M., Wallace R.B., Blazer D.G., Berkman L.F. Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. Psychosom Med. 57:1995;427-435.
36. Thaulow E., Erikssen J., Sandvik L., Stormorken H., Cohn P.F. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 84:1991;613-617.
37. Wells K.B. The role of depression in hypertension-related mortality. Psychosom Med. 57:1995;436-438.
38. Wilson J., Orchard M.A., Prentice C.R.M., et al. Treatment of hypertension induces a fall in platelet basal cytoplasmic calcium concentration without influencing platelet aggregation. Thromb Haemost. 68:1992;683-686.